However, the adaptive upregulation of SLC7A11 and GPX4 hinders radiotherapy efficacy; hence, inactivating SLC7A11 or GPX4 with ferroptosis inducers yields radioresistant cancer cells and xenograft tumors [266]. Here, SLC7A11 is linked to cancer.